Systemic Autoinflammatory Diseases-clinical Rheumatic Challenges - (hardcover) : Target,Systemic Autoinflammatory Diseases-clinical Rheumatic Challenges - (hardcover) : Target,Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis | Annals of the Rheumatic Diseases,Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease | Annals of the Rheumatic Diseases,Systemic autoinflammatory diseases: Clinical state of the art - ScienceDirect